ABUS vs JNJ: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Johnson & Johnson in 2026
ABUS
Arbutus Biopharma Corp
—
JNJ
Johnson & Johnson
$263.04
Key Metrics Comparison
| Metric | ABUS | JNJ | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $375.37B | JNJ |
| P/E Ratio | 5.39 | 17.35 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or JNJ a better investment?
Comparing ABUS and JNJ: Arbutus Biopharma Corp has a market cap of $882.99M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and JNJ?
ABUS (Arbutus Biopharma Corp) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or JNJ?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 17.4x).
Which is growing faster: ABUS or JNJ?
Both ABUS and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $882.99M for ABUS.
Should I buy ABUS or JNJ in 2026?
Both ABUS and JNJ have investment merit. ABUS trades at $N/A while JNJ trades at $263.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and JNJ stock?
Key differences: Market Cap ($882.99M vs $375.37B), P/E Ratio (5.4x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or JNJ in 2026?
The choice between ABUS and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and JNJ?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.